PEGylation of glucagon-like protein-1 (GLP-1) for the treatment of type 2 diabetes in vivo in diabetic mice has been reported where GLP-1 was conjugated with PEG (molecular weight 1, 2, or 5 kDa) [41]. Here, GLP1R is linked to type 2 diabetes mellitus.